Cytodyn Inc
OTC:CYDY
Cytodyn Inc
Other
Cytodyn Inc
Other Peer Comparison
Competitive Other Analysis
Latest Figures & CAGR of Competitors
Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cytodyn Inc
OTC:CYDY
|
Other
$474k
|
CAGR 3-Years
-64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other
-$527m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other
-$261m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other
-$134m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other
-$290.6m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other
-$947.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
See Also
What is Cytodyn Inc's Other?
Other
474k
USD
Based on the financial report for Nov 30, 2023, Cytodyn Inc's Other amounts to 474k USD.
What is Cytodyn Inc's Other growth rate?
Other CAGR 3Y
-64%
Over the last year, the Other growth was -80%. The average annual Other growth rates for Cytodyn Inc have been -64% over the past three years .